Lung Cancer

LUNG CANCER NEWS TIPS & FEATURES

Keytruda® Data Demonstrating Activity in Mesothelioma Presented at 17th World Conference on Lung Cancer

January 3rd, 2017

Keytruda® Data Demonstrating Activity in Mesothelioma Presented at 17th World Conference on Lung Cancer

Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) were featured in an oral presentation at the 17th World Conference […]


Keytruda® Active in Small Cell Lung Cancer

December 28th, 2016

Keytruda® Active in Small Cell Lung Cancer

Recently updated findings from the phase 1b KEYNOTE-028 study investigating the use of Keytruda® (pembrolizumab) in small cell lung cancer (SCLC) were recently presented at […]


Tagrisso®: New Standard of Care for Certain Lung Cancer

December 19th, 2016

Tagrisso®: New Standard of Care for Certain Lung Cancer

Treatment with the targeted agent Tagrisso (osimertinib) significantly delayed cancer progression, and resulted in fewer side effects, than standard chemotherapy for patients with advanced non-small […]


Pass It On: It’s National Lung Cancer Awareness Month

November 2nd, 2016

Pass It On: It’s National Lung Cancer Awareness Month

There are several types of lung cancer: non-small cell lung cancer (NSCLC), small cell lung cancer (SCLC), mesothelioma and lung carcinoid tumors, with NSCLC and […]


Precision Medicine Guides NSCLC Cancer Treatment: All Patients Should Undergo Molecular Testing

October 27th, 2016

Precision Medicine Guides NSCLC Cancer Treatment: All Patients Should Undergo Molecular Testing

Lung cancer remains the leading cause of cancer-related deaths worldwide. In the United States, non-small cell lung cancer (NSCLC) accounts for 75–80% of all lung […]


Keytruda Approved for First-Line Treatment of Select Patients with Advanced Non-Small Cell Lung Cancer

October 25th, 2016

Keytruda Approved for First-Line Treatment of Select Patients with Advanced Non-Small Cell Lung Cancer

The US Food and Drug Administration (FDA) has approved Keytruda® (pembrolizumab) as a first-line treatment options for patients with metastatic non-small cell lung cancer (NSCLC) […]


Tecentriq® Improves NSCLC Survival Compared to Chemotherapy Regardless of PD-L1 Status

October 25th, 2016

Tecentriq® Improves NSCLC Survival Compared to Chemotherapy Regardless of PD-L1 Status

Tecentriq® (atezolizumab) improves the outcomes of individuals with advanced non-small cell lung cancer (NSCLC) according to the results of a pivotal clinical trial presented at […]


FDA Approves Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer

October 20th, 2016

FDA Approves Genentech’s Cancer Immunotherapy Tecentriq® (Atezolizumab) for People with a Specific Type of Metastatic Lung Cancer

Genentech, a member of the Roche Group announced that the U.S. Food and Drug Administration (FDA) approved Tecentriq® (atezolizumab) for the treatment of people with […]


Immunotherapy May Become New Standard of Care in Advanced Non-Small Cell Lung Cancer

October 19th, 2016

Immunotherapy May Become New Standard of Care in Advanced Non-Small Cell Lung Cancer

Researchers presented full results of Keytruda® (pembrolizumab) and Opdivo® (nivolumab) in previously untreated advanced non-small cell lung cancer (NSCLC) at the European Society for Medical Oncology […]


Patient Panel on Non-Small Cell Lung Cancer Addresses Key Issues

October 14th, 2016

Patient Panel on Non-Small Cell Lung Cancer Addresses Key Issues

Voices of Value Speak Up: Non-Small Cell Lung Cancer is the first part of a national six-event program presented by Patients Rising and Aimed Alliance. […]


More News →